SalehAAlqahtaniMD
Gastroenterology • Baltimore, MDGastrointestinal Cancer, Hepatology & Liver Transplantation, Nutrition, Bariatric Medicine
Professor of Medicine, King Faisal Specialist Hospital & Research Center, Associate Professor of Medicine, Johns Hopkins University
Dr. Alqahtani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
1830 Bldg RM 420
Baltimore, MD 21287Phone+1 410-955-3779
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2007 - 2008
King Abdulaziz University College of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2024 - 2026
DC State Medical License 2014 - 2026
FL State Medical License 2023 - 2026
MD State Medical License 2012 - 2026
OH State Medical License 2020 - 2026
VA State Medical License 2018 - 2026
NY State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- National Board of Physicians and Surgeons Gastroenterology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Transplant Hepatology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059) Start of enrollment: 2014 May 09
- Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis Start of enrollment: 2014 Sep 18
- A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) Start of enrollment: 2014 Oct 28
Publications & Presentations
PubMed
- Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD.Assim A Alfadda, Adel N Alqutub, Suphia M Sherbeeni, Abdullah S Aldosary, Saleh A Alqahtani
Journal of Diabetes and Its Complications. 2024-11-20 - Food Swamps and Food Deserts Impact on Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality in U.S. Counties.Annette Paik, Linda Henry, Leyla de Avila, Saleh AlQahtani, Fatema Nader
Clinical Gastroenterology and Hepatology. 2024-11-13 - 1 citationsA systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities.Hussain A Al-Omar, Ali Alshehri, Saleh A Alqahtani, Hana Alabdulkarim, Ali Alrumaih
Saudi Pharmaceutical Journal. 2024-11-01
Press Mentions
Cefazolin Ranks Sixth as a Cause of Drug-Induced Liver InjuryJuly 1st, 2015
Hepatitis C Combo Pill May Cure Those Who Can Afford ItNovember 15th, 2017
5 Ways to Be Kind to Your LiverNovember 24th, 2017
Professional Memberships
- Member
- Member
Other Languages
- Arabic
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/saleh-alqahtani
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
